PlainIndex
Menu

ETF comparison

IBB vs IXJ

Both Healthcare.

iShares Biotechnology ETF · iShares Global Healthcare ETF

Holdings overlap

Weighted by ISIN/CUSIP
8.4 %

9 positions appear in both funds. Buying equal dollars of IBB and IXJ would leave roughly 8.4% of each dollar exposed to the same underlying securities.

IBB only 101.3% Shared 8.4% IXJ only 91.1%
In IBB only
247 positions
Shared
9 positions
In IXJ only
104 positions

Side by side

IBB

iShares Biotechnology ETF

iShares · Healthcare

69 composite / 100
Expense ratio
0.44%
Net assets
$9.09B
TTM yield
0.22%
Top-10 conc.
54.7%
IXJ

iShares Global Healthcare ETF

iShares · Healthcare

68 composite / 100
Expense ratio
0.40%
Net assets
$3.84B
TTM yield
1.47%
Top-10 conc.
45.8%

Sub-score comparison

56
Cost
60
85
Tax efficiency
83
98
Liquidity
82
36
Concentration
49
—
Tracking quality
—
IBB sub-score IXJ

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

IXJ is 4 bps cheaper than IBB. On a $100,000 position that's about $40/yr more in fees for IBB.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with IBB vs IXJ.

Top shared holdings

9 shared in total
# Holding In IBB In IXJ Overlap
1 Amgen, Inc. 7.51% 2.51% 2.51%
2 Gilead Sciences, Inc. 7.75% 2.29% 2.29%
3 Vertex Pharmaceuticals, Inc. 7.44% 1.50% 1.50%
4 Regeneron Pharmaceuticals, Inc. 7.21% 1.03% 1.03%
5 Biogen, Inc. 2.46% 0.36% 0.36%
6 Moderna, Inc. 1.68% 0.23% 0.23%
7 Incyte Corp. 1.70% 0.21% 0.21%
8 Charles River Laboratories International, Inc. 0.77% 0.12% 0.12%
9 Bio-Techne Corp. 0.74% 0.11% 0.11%

Only in IBB

247 total
  • BlackRock Funds III 9.66%
  • Alnylam Pharmaceuticals, Inc. 3.99%
  • Insmed, Inc. 3.20%
  • Argenx SE 3.07%
  • Natera, Inc. 2.41%
  • United Therapeutics Corp. 2.30%
  • BeOne Medicines Ltd. 1.93%
  • Illumina, Inc. 1.68%
  • Revolution Medicines, Inc. 1.54%
  • Roivant Sciences Ltd. 1.24%

Only in IXJ

104 total
  • ELI LILLY AND COMPANY 9.44%
  • JOHNSON & JOHNSON 7.63%
  • ABBVIE INC. 4.98%
  • ASTRAZENECA PLC 4.02%
  • MERCK & CO., INC. 3.96%
  • Novartis AG 3.87%
  • Roche Holding AG 3.72%
  • UNITEDHEALTH GROUP INCORPORATED 3.25%
  • THERMO FISHER SCIENTIFIC INCORPORATED 2.45%
  • ABBOTT LABORATORIES 2.37%

Open IBB or IXJ at a brokerage

Both funds trade commission-free at major US brokerages.

Open at Fidelity

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.